Concord Biotech

{
  "main_header": {
    "sid": 10038977,
    "name": "Concord Biotech",
    "stock_name": "Concord Biotech",
    "full_name": "Concord Biotech Ltd",
    "name_url": "stocks-analysis/concord-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,580.75",
    "chg": 86.85,
    "chgp": "5.81%",
    "dir": 1,
    "prev_price": "1,493.90",
    "mcapval": "16,121.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543960,
    "symbol": "CONCORDBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE338H01029",
    "curr_date": "Sep 21, 03:30 PM",
    "curr_time": "07:56 AM",
    "last_traded_at": "Sep 21, 03:30 PM IST",
    "bse_nse_vol": "5.9 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-signal-bullish-outlook-4196812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4196812.png",
        "date": "2026-09-18 08:04:50",
        "description": "Concord Biotech Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by improvements in key technical indicators such as the Moving Average Convergence Divergence (MACD), Bollinger Bands, and daily moving averages, signalling potential upside for investors amid a challenging pharmaceutical sector backdrop."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4195695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4195695.png",
        "date": "2026-09-17 08:05:11",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s technical indicators suggest a cautiously optimistic outlook, supported by an upgrade in its Mojo Grade from Sell to Hold as of 31 July 2026."
      },
      {
        "title": "Concord Biotech Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-hold-4195162",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_mojoScore_4195162.png",
        "date": "2026-09-16 10:10:03",
        "description": "Concord Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-signal-bullish-outlook-4194321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4194321.png",
        "date": "2026-09-16 08:09:50",
        "description": "Concord Biotech Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent 2.33% decline in its share price to ₹1,471.50. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex but cautiously optimistic outlook for this small-cap pharmaceutical and biotechnology player."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4189866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4189866.png",
        "date": "2026-09-11 08:05:14",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a nuanced shift in its technical momentum. While some indicators suggest a cautiously optimistic outlook, others reveal underlying bearish pressures, reflecting a complex market sentiment as the stock navigates a challenging environment."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-signal-bullish-outlook-4187324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4187324.png",
        "date": "2026-09-09 08:05:57",
        "description": "Concord Biotech Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by key indicators such as MACD, Bollinger Bands, and moving averages. This technical evolution, coupled with the company’s recent price performance and relative strength against the Sensex, suggests a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Concord Biotech Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-hold-4183138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_mojoScore_4183138.png",
        "date": "2026-09-05 10:10:29",
        "description": "Concord Biotech Ltd is rated Hold by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4176968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ConcordBiotechL_technicaldot_4176968.png",
        "date": "2026-09-01 08:07:30",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s technical indicators reveal a cautiously optimistic outlook, prompting a reassessment of its market positioning and investor sentiment."
      },
      {
        "title": "Concord Biotech Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-hold-4168766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ConcordBiotechL_mojoScore_4168766.png",
        "date": "2026-08-25 10:10:04",
        "description": "Concord Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 450,
    "sid": "10038977",
    "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting To Be Held On Wednesday September 23 2026 Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 Inter-Alia To Consider The Proposal For Declaration Of Bonus Equity Shares To The Existing Equity Shareholders Of ",
      "datetime": "19-Sep-2026",
      "details": "Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2026 inter alia to consider and approve the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions subject to approval of the shareholders of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Outcome Of U.S. Food And Drug Administration (USFDA) Inspection At Unit II - Valthera Formulation Facility Of The Company",
      "datetime": "18-Sep-2026",
      "details": "Intimation of Outcome of U.S. Food and Drug Administration (USFDA) Inspection at Unit II - Valthera Formulation Facility of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Sep-2026",
      "details": "Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we would like to inform you that the officials of the Company will be meeting investors/analysts on September 23 2026 at 12:30 P.M.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "23 Sep 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has declared <strong>755%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-18 08:04:50

Concord Biotech Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by improvements in key technical indicators such as the Moving Average Convergence Divergence (MACD), Bollinger Bands, and daily moving averages, signalling potential upside for investors amid a challenging pharmaceutical sector backdrop.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-17 08:05:11

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s technical indicators suggest a cautiously optimistic outlook, supported by an upgrade in its Mojo Grade from Sell to Hold as of 31 July 2026.

Read full news article

Concord Biotech Ltd is Rated Hold

2026-09-16 10:10:03

Concord Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-16 08:09:50

Concord Biotech Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent 2.33% decline in its share price to ₹1,471.50. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex but cautiously optimistic outlook for this small-cap pharmaceutical and biotechnology player.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-11 08:05:14

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a nuanced shift in its technical momentum. While some indicators suggest a cautiously optimistic outlook, others reveal underlying bearish pressures, reflecting a complex market sentiment as the stock navigates a challenging environment.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-09 08:05:57

Concord Biotech Ltd has demonstrated a notable shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by key indicators such as MACD, Bollinger Bands, and moving averages. This technical evolution, coupled with the company’s recent price performance and relative strength against the Sensex, suggests a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Concord Biotech Ltd is Rated Hold

2026-09-05 10:10:29

Concord Biotech Ltd is rated Hold by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-01 08:07:30

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s technical indicators reveal a cautiously optimistic outlook, prompting a reassessment of its market positioning and investor sentiment.

Read full news article

Concord Biotech Ltd is Rated Hold

2026-08-25 10:10:04

Concord Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News